This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 9, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17735, first published .
Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial

Authors of this article:

Lubaba Shahrin1 Author Orcid Image ;   Mohammod Jobayer Chisti1 Author Orcid Image ;   Abu Sadat Mohammad Sayeem Bin Shahid1 Author Orcid Image ;   Abu Sayem Mirza Mohammad Hasibur Rahman1 Author Orcid Image ;   Md. Zahidul Islam1 Author Orcid Image ;   Farzana Afroze1 Author Orcid Image ;   Sayeeda Huq1 Author Orcid Image ;   Tahmeed Ahmed1 Author Orcid Image
Article Authors Cited by (4) Tweetations (1) Metrics

Lubaba Shahrin   1 , MBBS, FCPS ;   Mohammod Jobayer Chisti   1 , MBBS, MMed, PhD ;   Abu Sadat Mohammad Sayeem Bin Shahid   1 , MBBS ;   Abu Sayem Mirza Mohammad Hasibur Rahman   1 , MBBS ;   Md. Zahidul Islam   1 , MS ;   Farzana Afroze   1 , MBBS, FCPS ;   Sayeeda Huq   1 , MBBS, MPH ;   Tahmeed Ahmed   1 , MBBS, PhD

1 International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh

Corresponding Author: